Background: The current guidelines recommend the screening of all cirrhotic patients by endoscopy, but repeated endoscopic examinations are unpleasant for patients and have a high cost impact and burden on endoscopic units. Recognition of non-invasive predictors of oesophageal varices (OV) will allow upper gastrointestinal tract (GIT) endoscopy to be carried out only in a selected group of patients, thus avoid unnecessary intervention and at the same time not to miss patients at risk of bleeding. Objective: the aim of this study was to evaluate the validity of three non-invasive parameters in the prediction of esophageal varices in patients with compensated hepatitis C virus (HCV) induced liver cirrhosis namely insulin resistance, platelet count/spleen diameter ratio and right liver lobe diameter/albumin ratio. Methods: This prospective study included one hundred non-diabetic, non-obese patients with Child A HCV induced cirrhosis. All studied patients underwent a detailed history, thorough physical examination, biochemical workup, upper gastrointestinal endoscopy and abdominal ultrasound. Insulin resistance (IR) by the homeostasis model assessment (HOMA), the platelet count/spleen diameter ratio and the right liver lobe diameter /albumin concentration ratio for all patients were calculated. Results: The prevalence of oesophageal varices in Child A HCV induced cirrhosis were high, as 79 patients had oesophageal varices (79%). The 3 predictors demonstrated a high statistically significant correlation with the presence and grade of oesophageal varices (P values < 0.001). Among the 3 non-invasive predictors, the HOMA-IR score gave the highest accuracy at a cut-off value of 3. The next highest accuracy was associated with the platelet count/spleen diameter ratio at a cut-off value of 750. The least accurate of the 3 non-invasive predictors was Right liver lobe diameter /albumin ratio at a cut-off value of 3.5. Conclusion: Insulin resistance measured by HOMA-IR, Platelet count/Spleen diameter ratio, as well as the right liver lobe diameter/Albumin concentration ratio are non-invasive parameters that can provide accurate information pertinent to determination of the presence and grade of esophageal varices in patients with Child A HCV induced cirrhosis and can help physicians to restrict the use of endoscopic screening only to patients presenting a high probability of oesophageal varices. This is especially useful in clinical settings where resources are limited and endoscopic facilities are not present in all areas. Such is the case in Egypt, where there is a large number of patients who require screening for oesophageal varices. Keywords: Noninvasive diagnosis of oesophageal varices, Insulin resistance, Platelet count / spleen diameter ratio, right liver lobe size / albumin ratio, HCV related liver cirrhosis.
INTRODUCTION
pproximately 170 million people worldwide are chronically infected by HCV, which can result in progressive hepatic injury and fibrosis, resulting in cirrhosis and end-stage liver diseases (1). Egypt receives the highest prevalence of HCV worldwide (15%) (2). In 2011 WHO, stated that Egypt has the highest prevalence in the world, which is 22% (3).
Portal hypertension (PH), defined by a hepatic venous pressure gradient (HVPG) greater than 6mmHg is a common complication of cirrhosis. The development of esophageal varices (EV) is a clinical manifestation of PH with a prevalence that can range from 40% to 80% in patients with cirrhosis. This prevalence increases progressively in relation to the severity of liver damage (4).The clinical course of compensating cirrhosis classified according to presence of esophageal varices into compensating cirrhosis with absence (stage 1) or the presence of varices (stage 2) with significant morbidity and mortality and clinical outcome rates in compensated cirrhotic patients with varices (stage 2) (5).
Upper gastrointestinal bleeding (UGB) caused by rupture of gastric and mainly, esophageal varices (EV) are the most dramatic complication of cirrhosis. Bleeding caused by its rupture implies a mortality rate of 17% to 57% to this kind of patients (6). HVPG and endoscopy are current gold-standard techniques to assess portal hypertension and oesophageal varices. However, its use is limited by their invasiveness and screening all patients with endoscopy to guide therapy may significantly increase the cost (7).
Endoscopic screening of all patients with liver cirrhosis would result in a large number of unnecessary endoscopies and additional burden to endoscopy units (8) .
In Egypt, the management of patients with liver cirrhosis complicated by the interplay between clinical, economic, social, and cultural factors and the generally poor compliance to both follow-up and treatment strategies (9).
A method of predicting the presence of EVs noninvasively is in great demand to avoid unnecessary endoscopy and improve the cost effectiveness of management; the latter is a particularly important consideration in many African and Middle Eastern countries, including Egypt, where liver cirrhosis is highly prevalent (9).
Ideally, a method for identifying patients with varices should be simple, noninvasive, inexpensive, reproducible, accurate, and readily available; have high sensitivity and specificity; follow the natural history; reflect the effect of the treatment accurately; and indicate the prognosis and possibility of the success of a treatment (7).
The aim of this study was to evaluate the validity of three non-invasive parameters in the prediction of esophageal varices in patients with compensated hepatitis C virus induced cirrhosis namely insulin resistance, platelet count/spleen diameter ratio and right liver lobe diameter/albumin ratio.
PATIENTS AND METHODS This is an observational, descriptive, analytical study carried out in the Gastroenterology and Hepatology unit, Internal Medicine Department in collaboration with Clinical Pathology Department, Faculty of Medicine, Zagazig University during the period from January 2012 to January 2014.
Patients
This study included 100 non-diabetic, nonobese patients with Child A HCV induced cirrhosis who were under investigation and/or treatment in outpatient clinics, or patients referred to the hospital endoscopy unit for endoscopic screening for the presence of oesophageal varices. All patients supplied informed consent before participating in this study.
Inclusion Criteria
Patients were included after they had a diagnosis of HCV induced cirrhosis based on histopathological examination of liver biopsy whenever available or clinical criteria based on (history, physical examination, laboratory parameters and imaging findings) (5). Exclusion Criteria Patients excluded if they had: Esophageal varices were graded according to their size; a grading classification of I-IV was used (11).
Grade I: was used for varices in the level of mucosa. Grade II: for varices smaller than 5 mm filling less than 1/3 of the oesophageal lumen.
Grade III: for varices larger than 5mm filling more than 1/3 of the oesophageal lumen Grade IV: for varices occupied more than 2/3 of oesophageal lumen.
 Liver biopsy. Done guided by ultrasonography by core biopsy needle in a single radiology unit by an experienced radiologist.
 Insulin resistance (IR) 
STATISTICAL ANALYSIS:
Quantitative data expressed as mean  standard deviation (SD) or standard error (SE). SE=SD/square root of patients' number which was used in case of big SD, data was analyzed by independent sample, paired t test and one way analysis of variance (ANOVA). While qualitative data were expressed as number and percentage and were analyzed by Chi square (X 2 ) test. The correlation was done using a Pearson correlation test. The receiver operating characteristic (ROC) curve and 95% confidence interval (CI) was performed to determine cutoff values for the studied biomarkers. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were determined. P value was considered significant if < 0.05 and highly significant if < 0.001.
RESULTS
This study comprised 100 patients with Child A HCV induced cirrhosis, 40 patients were included after they had been diagnosed as cirrhosis based on histopathological examination of liver biopsy, 60 patients were included after they had been diagnosed as cirrhosis based on history, physical examination, biochemical parameters, and ultrasonographic finding. kg/m 2 . Overall 9 of 100 patients (9%) had normal weight and 91 of 100 (91%) were overweight. 13 of patients (13%) were smoker . Figure1 ) show that 21 patients had no varices (21%), 79 patients had Varices (79%); they were Grade I in 19 patients (24 %), Grade II in 47 patients (59.5%) and Grade III in 13 patients (16.5%). 9 patients (11.3 %) had gastric varices with 5 of them (6.3%) had also OV Grade I and 4 patients (5%) had OV Grade II. With all patients with isolated gastric varices were excluded from the study because of possibility of compartmental portal hypertension. Table ( 3) shows that, the mean value for WBCs was (5.6 ± 1.6), hemoglobin was (12.7 ± 1.4), platelet was (96.7 ± 20. Table ( 4) shows that, the mean portal vein diameter was (12.5 ± 1.6) mm with rang was (10-17) mm, spleen bipolar diameter was (149.1 ± 20.2) mm with rang was (105-220) mm, and right liver lobe diameter was (149 ± 21.1) mm with rang was (130-230) mm. Table ( 5) shows that The HOMA-IR was (4.36 ± 2.6) with rang was (1.22-15.6), platelet count/spleen bipolar diameter ratio was (657.2 ± 191.6) with rang was (352-1047), and right liver lobe diameter /albumin ratio was (3.86 ± 0.55) with rang was (3.02-6.17). 
VARICES

Analysis of data t test P Value
HOMA-IR score PLT count, n/ ul/spleen ratio, mm Right liver lobe, cm /albumin, gm/dl. ratio 2.2 ± 0.6 849.1 ± 226 3.48 ± 0.4 4.9 ± 2.6 606.1 ± 144. 6 3.96 ± 0.5 4.6 < 0.001 6.01 < 0.001 3.75 < 0.001 Table ( 7) shows that, the tested three parameters were all associated with the presence of varices (P <0.001). With the mean value of the three parameters in detection of the Varices were, high HOMA-IR score (4.9 ± 2.6), low platelet count/spleen diameter ratio (606.1 ± 144.6) and high Right liver lobe diameter /albumin ratio (3.96 ± 0.5). Table ( Table ( 9) shows that, when we compared the mean values of HOMA-IR score, platelet count/spleen diameter ratio between pateints with no varices and pateints with different grades of varices highly significant were noted with (P < 0.001), and when we compared the mean values of right liver lobe diameter /albumin ratio between pateints with no varices and pateints with different grdes of varices also, significant were noted with (P = 0.003). Table ( 10) shows that, when we tested the least significant difference (LSD) of the means of the three parameters, there are significant difference between pateints with no varices and pateints with different grades of varices with (P < 0.001). Also, there are significant difference between the pateints with grade I varices and pateints with grade II varices with (P < 0.05). But, no significant difference between pateints with grade I varices and pateints with grade II of varices and between pateints with grade II varices and pateints with grade III of varices
Table (10): Least Significant Difference of the Three Parameters and Pattern of Varices
NS: not significant
Patient with no varices
Grade I Grade II Grade III P < 0.001 P < 0.05 NS Grade II P < 0.001 NS Grade I P < 0.001 Table ( 11) shows that, When we tested the correlations between the three parameters and grades of varices, there are positive correlation between HOMA-IR score and grades of varices (Correlation Coefficient (r) = + 0.4; P-Value < 0.001), there are negative correlation between platelet count/spleen bipolar diameter ratio and grades of varices (r = -0.39 ; P < 0.01) and there are positive correlation between right liver lobe diameter /albumin ratio and grades of varices (r = + 0.35; P < 0.05).
ROC Curve
Diagonal segments are produced by ties. Figure 5) shows that, among the 3 noninvasive predictors, the HOMA-IR score gave the highest accuracy at a cut-off value of 3. The next highest accuracy was the platelet count/spleen diameter ratio at a cut-off value of 750. The least accurate of the 3 non-invasive predictors was right liver lobe diameter /albumin ratio at a cut-off value of 3.5.
DISCUSSION
Because of, the impact of UGB caused by rupture of EV in the prognosis of cirrhotic patients, the Baveno IV 2005 Consensus Workshop (13) and the American Association for the Study of Liver Diseases (AASLD) have determined that every patient diagnosed with cirrhosis should be investigated for EV, regardless of Child class and cause. In patients who have compensated cirrhosis and no varices on the initial EGD, it should be repeated in 3 years. If there is evidence of hepatic decompensation, EGD should be done at that time and repeated annually (14).
Several non-invasive methods have emerged in recent years, assessing the potential of various laboratory, clinical, and ultrasonographic parameters, linked directly or indirectly to portal This study was conducted on 100 nondiabetic, non-obese patients with Child A HCV induced cirrhosis with forty patient had a diagnosis of HCV induced cirrhosis based on histopathological examination of liver biopsy and sixty patient had a diagnosis of cirrhosis based on physical findings, laboratory investigations, and ultrasonographic findings because of absence of liver biopsy.
In this study, the prevalence of OV in Child A HCV induced cirrhosis were high, as 79 patients had oesophageal varices (79%), 9 of them had also gastric varices. In a multi-centered study conducted In 3 centers (2 in Spain and 1 in Egypt) on 2 sets of newly diagnosed cirrhotic patients (total n = 357) OV was recorded in 75 % of patients of first set and in 76 % in second set (23).
In another study on Egyptian patients Yosry et al (2009) stated that 83% of patients had oesophageal varices (24) and in another study by Esmat and Omran (2011) the prevalence of oesophageal varices was 82% (25).
Univariate analysis of factors associated with presence of varices showed that, patients who got OV were characterized by being, elder, males more than females, more smoker, with higher body mass index, lower Platelet counts, higher fasting insulin level, higher fasting blood glucose, higher spleen diameter, higher portal vein diameter.
Several studies have shown that high portal vein diameter (26), splenomegaly (27) and low platelet count (28) serve as predictors of EV presence.
Also, the tested three parameters with high HOMA-IR score, low platelet count/spleen diameter ratio and high right liver lobe diameter /albumin ratio were all associated with the presence and grade of varices.
However Giannini et al (2003) introduced the use of the platelet count/spleen diameter ratio as a tool to predict oesophageal varices. This ratio links thrombocytopenia to splenomegaly to introduce a variable that takes into consideration that thrombocytopenia is mainly due to hypersplenism secondary to portal hypertension. In that study, when a cut-off value of 909 used, the sensitivity was 100%, and the specificity was 93% (29).
Giannini et al (2006)
reported the results of a multicentre study to validate the use of platelet count/spleen diameter ratio in the prediction of oesophageal varices. At a cut-off value of 909, the sensitivity was 92%, and the specificity was 67% Patient having the ratio greater than cut-off value should not receive nonselective beta-blockers prophylactic therapy because they are less likely to develop esophageal varices. These patients should less frequently undergo endoscopy (18).
Several studies have been performed using different best cut-off values to investigate this parameter as a noninvasive predictor for oesophageal varices.
Agha et al (2009) studied 114 patients with compensated HCV related cirrhotics, 909 cut-off showed negative predictive value 100% and a positive predictive value of 93.8% for the diagnosis of EV (30).
Camma` et al (2009) studied 104 newly diagnosed patients with Child A HCV cirrhosis, identified a value of 792 as the best cutoff for the presence of esophageal varices and ratio greater than 792 Could be useful to identify patients at low risk of EV. And stated these, different results are perhaps related to differences in etiology and class of disease between the two populations as regard Giannini et al study (22) .
In one study on Egyptian patients Esmat et al (2012) concluded that a cut-off value of 1326.58 for the platelet count/spleen diameter ratio was used with a resulting 96.34% sensitivity, 83.33% specificity and 94% accuracy (31).
In another study also in Egyptian patients Abu El Makarem et al (2011) concluded that a cutoff value of 939.7 for the platelet count/spleen diameter ratio was used with a resulting 100% sensitivity, 86.3% specificity and 96.5% accuracy (9).
In this study, analysis of the area under the ROC curve (AUROC) revealed that the cut-off of the platelet count/spleen diameter ratio (750) was the optimal value for accurate prediction of EVs with a resulting 81% sensitivity, 81% specificity and 81% accuracy.
When we applied the same cut-off value of 909 Giannini used for the platelet count/spleen diameter ratio to the current study, the sensitivity and accuracy was significantly reduced to 65% and 73%, respectively.
The differences between the best cut-off values, sensitivity, specificity, and accuracy in this study and other studies may be attributed to several factors influencing the platelet count including infection, bleeding, drugs, and lower thrombopoietin levels in patients with liver cirrhosis. In addition, the absence of interobserver agreement between the sonographers and endoscopists of the different studies which can affect the results.
Regarding the right liver lobe diameter /serum albumin ratio Alempijevic et al (2007) had counted an original ratio. For the first time they reported the value of the right liver lobe diameter /serum albumin concentration in assessment of portal hypertension. They used serum albumin concentration as a parameter of liver function in combination with right liver lobe size and used this ratio as a non-invasive predictor of oesophageal varices with at a cut-off value of 4.425, the sensitivity was 83.1%, and the specificity was 73.9% (11).
In another study on Egyptian patients Esmat et al (2012) concluded that a cut-off value of 4.422 for the right liver lobe diameter/albumin concentration ratio gave sensitivity 91.46%, and the specificity 77.78% (31).
In this study, analysis of the area under the ROC curve (AUROC) revealed that the cut-off value for the right liver lobe diameter/albumin concentration ratio (3.5) was the optimal value for accurate prediction of EVs with a resulting 78.5 % sensitivity, 57.1 % specificity, and 74 % accuracy.
The results of this study are the same results of other study on Egyptian patients by Adel and George (2011). They investigate the right liver lobe diameter/albumin concentration ratio as a noninvasive predictor of oesophageal varices, with the best cut off value at 3.5 where sensitivity was 80 % and specificity was 70 % (32).
When we applied the same cut of value of 4.425 Alempijevic et al. used for the right liver lobe diameter/albumin concentration ratio to the current study, the sensitivity, and accuracy was significantly reduced to 12.7 % and 31%, respectively.
The differences between the best cut-off values, sensitivity, specificity, and accuracy in this study and Alempijevic study may be attributed to the different group of patient where all patients in this study were child A with the mean albumin concentration (3.87 ± 0.4). In the other study, the patients were child A, B and C with the mean albumin concentration (3.08± 0.8), also patients were had a different ethnic background. In addition, the differences between the sonographers of different studies, which can affect the results. This suggests the need for further multicenter studies including a large number of patients with different ethnic background for determining the best cut-off, value for that ratio.
Lastly Insulin resistance which is firstly introduced by Camma` et al (2009), which stat that Insulin resistance measured by HOMA-IR, regardless of the presence of diabetes, significantly predicts the presence of EV (22).
Studies in chronic liver diseases have shown a strong and independent pathogenic link between Insulin resistance (IR) and HCV infection and between IR and the severity of hepatic fibrosis (33).
Retrospective analyses have estimated that approximately 21-24% of chronic hepatitis C (CHC) patients are diabetic, with as many as 54% demonstrating IR (34).
Camma` et al (2009) studied 104 patients of Child A HCV induced cirrhosis conclude that HOMA-IR score of greater than 3.5 is the cut-off value with the best sensitivity 61% and specificity 76% for predicting EV presence and HOMA score less than 3.5 (if non-diabetic) could be useful to identify patients at low risk of EV (22).
